South Alabama Medical Science Foundation v. Gnosis S.P.A.

818 F.3d 1380, 2016 U.S. App. LEXIS 7504, 2016 WL 1695724
CourtCourt of Appeals for the Federal Circuit
DecidedApril 26, 2016
Docket2014-1778, 2014-1780, 2014-1781
StatusPublished

This text of 818 F.3d 1380 (South Alabama Medical Science Foundation v. Gnosis S.P.A.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
South Alabama Medical Science Foundation v. Gnosis S.P.A., 818 F.3d 1380, 2016 U.S. App. LEXIS 7504, 2016 WL 1695724 (Fed. Cir. 2016).

Opinions

[1381]*1381O’MALLEY, Circuit Judge, with whom WALLACH and STOLL, Circuit Judges, join, concur in the denial of the petition for rehearing en banc. NEWMAN, Circuit Judge, dissents from the denial of the' petition for rehearing en banc.

ORDER

PER CURIAM.

Appellant South-Alabama Medical Science Foundatioii filed a petition for rehearing en 'banc. A response to’ the petition was invited by the court and filed by the appellees Gnosis S.p.A., Gnosis Biore-search S.A., and Gnosis U.S.A:, Inc. -

The petition was referred to the1 panel that heard the appeal, and thereafter the petition and response were referred to the circuit judges who are in’ regular active service. A poll was reguested, taken, and failed.

Upon consideration thereof,
It Is Ordered That:

The petition’ for rehearing en banc is’ denied.

The mandate of the court will issue on May 3, 2016.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Graham v. John Deere Co. of Kansas City
383 U.S. 1 (Supreme Court, 1966)
Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.
566 F.3d 989 (Federal Circuit, 2009)
Stratoflex, Inc. v. Aeroquip Corporation
713 F.2d 1530 (Federal Circuit, 1983)
Leo Pharmaceutical Products, Ltd. v. Rea
726 F.3d 1346 (Federal Circuit, 2013)
Merck & Cie v. Gnosis S.P.A.
808 F.3d 829 (Federal Circuit, 2015)
Merck & Cie v. Gnosis S.P.A.
820 F.3d 432 (Federal Circuit, 2016)
Eurand, Inc. v. Mylan Pharmaceuticals Inc.
676 F.3d 1063 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
818 F.3d 1380, 2016 U.S. App. LEXIS 7504, 2016 WL 1695724, Counsel Stack Legal Research, https://law.counselstack.com/opinion/south-alabama-medical-science-foundation-v-gnosis-spa-cafc-2016.